# Optimizing Membrane Composition With C15 and Choline: A Novel Hypothesis to Mitigate Cancer Risk

**Authors:** Joseph Mercola

PMC · DOI: 10.7759/cureus.99954 · Cureus · 2025-12-23

## TL;DR

This paper proposes that adjusting diet to reduce linoleic acid and increase C15 and choline may help lower cancer risk by improving cell membrane health.

## Contribution

A novel hypothesis linking dietary lipid composition to cancer risk through membrane-mediated mechanisms.

## Key findings

- Rising cancer rates correlate with increased linoleic acid consumption and decreased C15 and choline intake.
- C15 and choline may protect against oxidative stress and inflammation by stabilizing cell membranes.
- Clinical trials are needed to test if correcting lipid imbalances can reduce cancer incidence.

## Abstract

Cancer incidence has dramatically increased over the past centuries, paralleling dietary shifts in Western nations. This narrative review evaluates whether excess dietary linoleic acid (LA) drives tumor initiation through membrane-mediated oxidative stress and chronic inflammation, and whether pentadecanoic acid (C15:0) and choline can restore membrane resilience and attenuate cancer risk. Historical epidemiological data and mechanistic studies reveal that rising cancer incidence tracks population-level LA exposure, while C15:0 and choline consumption have declined. In cellular and animal models, LA oxidation products activate pro-inflammatory and anti-apoptotic pathways. Conversely, C15:0 resists peroxidation and preserves mitochondrial integrity, while choline normalizes membrane fluidity. A precision-nutrition strategy restricting LA while fortifying C15:0 and choline offers a biochemically coherent complement to conventional oncology. Prospective clinical trials are warranted to validate whether correcting this lipid imbalance can reduce cancer incidence.

## Linked entities

- **Chemicals:** linoleic acid (PubChem CID 5280450), pentadecanoic acid (PubChem CID 13849), C15:0 (PubChem CID 13849), choline (PubChem CID 305)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** chronic inflammation (MESH:D007249), Cancer (MESH:D009369)
- **Chemicals:** C15 (MESH:C003946), Choline (MESH:D002794), lipid (MESH:D008055), LA (MESH:D019787), C15:0 (-), pentadecanoic acid (MESH:C117025)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12826826/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12826826/full.md

## References

175 references — full list in the complete paper: https://tomesphere.com/paper/PMC12826826/full.md

---
Source: https://tomesphere.com/paper/PMC12826826